Guided by the initial HPA tissue profiling, we measured the abundance of UGT1A transcripts v1, v2, and v3 using RNA-seq datasets generated from large cohorts of paired normal and tumor samples from the liver, kidney, colon/rectum, stomach, esophagus, and bladder. This evidence concerns the gene UGT1A1 and neoplasm.